Inhibiting oxidative stress and inflammation in acute lung injury using hydrogen: A preclinical systematic review and meta-analysis
Global Translational Medicine · 2023
DOI: 10.36922/gtm.0379 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Global Translational Medicine, 2023. Verfasst von Guoshen Zhong und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Acute lung injury (ALI) results from excessive inflammation and disruption of the alveolar-capillary barrier, leading to acute respiratory distress syndrome. Hydrogen, known as a reducing substance, has been commonly used in preclinical trials of ALI. The present paper aims to summarize the effects of hydrogen on animal models of ALI and the possible antioxidant and anti-inflammation mechanisms of hydrogen. We conducted a thorough search of the relevant literature on PubMed, EMBASE, Web of Science, and CNKI. Data retrieved from 20 studies were analyzed to assess the beneficial effects of hydrogen therapy on ALI animal models. To evaluate the effects of hydrogen, commonly assessed outcome indicators include wet-to-dry ratio (W/D), arterial oxygen partial pressure (PaO2), malondialdehyde (MDA), superoxide dismutase (SOD), and tumor necrosis factor-alpha (TNF-α). The results demonstrate that hydrogen reduces pulmonary edema (W/D: 95% CI = −0.98 – −0.85, P < 0.001), mitigates hypoxia (PaO2: 95% CI = 6.08 – 22.30, P < 0.001), represses lipid peroxidation (MDA: 95% CI = −2.12 – −1.06, P < 0.001), scavenges free radicals (SOD: 95% CI = 10.12 – 30.07, P < 0.001), and inhibits inflammatory response (TNF-α: 95% CI = −5.52 – −1.72, P < 0.001). The subgroup analysis showed significant differences between interventions (MDA: P < 0.05; TNF-α: P < 0.05; SOD: P < 0.001). The meta-regression suggests that species may cause heterogeneity (P < 0.05). These results suggest the potential of using hydrogen in clinical trials. Different interventions with hydrogen can affect metabolic transport and distribution in vivo. Further studies should be conducted to validate and confirm these findings.
Zitieren
APA
Zhong, G., Shi, Y., Kong, L., Lv, K., Zhang, L., Yang, M., Tian, N., & Yang, N. (2023). Inhibiting oxidative stress and inflammation in acute lung injury using hydrogen: A preclinical systematic review and meta-analysis. Global Translational Medicine. https://doi.org/10.36922/gtm.0379
Vancouver
Zhong G, Shi Y, Kong L, Lv K, Zhang L, Yang M, et al. Inhibiting oxidative stress and inflammation in acute lung injury using hydrogen: A preclinical systematic review and meta-analysis. Global Translational Medicine. 2023. doi:10.36922/gtm.0379
BibTeX
@article{Zhong2023,
author = {Zhong, Guoshen and Shi, Yanhua and Kong, Lingyu and Lv, Kaixuan and Zhang, Lichun and Yang, Mei and Tian, Na and Yang, Nana},
title = {Inhibiting oxidative stress and inflammation in acute lung injury using hydrogen: A preclinical systematic review and meta-analysis},
journal = {Global Translational Medicine},
year = {2023},
doi = {10.36922/gtm.0379}
}
EUVIMED